Insights from 2023 SABCS


 

SABCS 2023 Insights: "CDK4/6 Inhibition as a Potential Vulnerability in NF1-Depleted ER+ Breast Cancer"

90 views
January 3, 2024
Comments 0
Login to view comments. Click here to Login